Monday, October 22, 2018
- 9:00AM-11:00AM
-
Abstract Number: 1355
Asymptomatic Hyperuricemia Is Associated with Increased Prevalence of Symptomatic Knee Osteoarthritis: Data from Third National Health and Nutrition Examination Survey
Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1596
Atherosclerotic Cardiovascular Disease in Psoriatic Arthritis: Evaluation of Risk Factor Management and Use of Aspirin and Statin for Prevention in a Primary Care Setting
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies- 9:00AM-11:00AM
-
Abstract Number: 1274
Atmospheric Temperature and the Incidence of Gout Flare: Data from the Korea Meteorological Association and National Health Insurance Service
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I- 9:00AM-11:00AM
-
Abstract Number: 1713
Attainment of Low Disease Activity and Remission in SLE Patients Who Started with High Disease Activity in the Atacicept Phase IIb Address II Study and Its Long-Term Extension
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1314
Autoantibodies and Clinical Outcomes in Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis- 9:00AM-11:00AM
-
Abstract Number: 1307
Autoantibodies in Idiopathic Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features – a Prospective Study
Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis- 9:00AM-11:00AM
-
Abstract Number: 1574
Autoantibodies Present in Saliva from Sjogren’s Syndrome and Non-Sjogren’s Sicca Patients Are Not Detectible in Serum
Sjögren's Syndrome – Basic and Clinical Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1699
Autoantibodies to M-Phase Phosphoprotein I (MPP-1: KIF20B) in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes- 9:00AM-11:00AM
-
Abstract Number: 1341
Autoantibodies to Mi-2 Alpha and Mi-2 Beta in Patients with Myositis
Muscle Biology, Myositis and Myopathies Poster II: Basic and Translational Science- 9:00AM-11:00AM
-
Abstract Number: 1423
Autoantibody Testing in Pediatric Localized Scleroderma (LS)
Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 1017
Autoantigen Pentraxin-3 Is an Inflammatory Cytokine Storms Suppressor By Switching Monocytes Pyroptosis to Apoptosis in a Complement-Dependent Manner in Rheumatoid Arthritis
Innate Immunity Poster- 9:00AM-11:00AM
-
Abstract Number: 1026
Autoinflammatory Diseases, Particularly SAVI and Candle, Are Driven By Chronically Active Type I Interferons
Innate Immunity Poster- 9:00AM-11:00AM
-
Abstract Number: 1075
Automated Multiparameter Microscopy and Image Analysis: Next Generation Synovial Tissue Histology
Rheumatoid Arthritis – Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1353
Autophagy Marker LC3 Accumulates in Immune-Mediated Necrotizing Myopathy Muscle Fibres